Monday, 17 June 2019, Erganeo and the start-up Orixha signed an exclusive worldwide license for the use of an innovative liquid ventilation technology, inducing ultra-fast therapeutic hypothermia in the vital organs of patients suffering from cardiac arrest. This win-win relationship shows Erganeo’s strengthened commitment to its start-ups.

Read the press release